- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 4 residues within 4Å:- Chain A: E.93, H.94, N.95, N.231
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.4: 2 residues within 4Å:- Chain A: D.187, N.316
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.5: 2 residues within 4Å:- Chain A: P.330, N.331
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.20: 4 residues within 4Å:- Chain B: E.93, H.94, N.95, N.231
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.22: 2 residues within 4Å:- Chain B: D.187, N.316
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.23: 2 residues within 4Å:- Chain B: P.330, N.331
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.38: 4 residues within 4Å:- Chain C: E.93, H.94, N.95, N.231
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.40: 2 residues within 4Å:- Chain C: D.187, N.316
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.41: 2 residues within 4Å:- Chain C: P.330, N.331
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.6: 8 residues within 4Å:- Chain A: A.69, K.70, Y.71, N.265, S.281, N.282, N.342, E.456
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.24: 8 residues within 4Å:- Chain B: A.69, K.70, Y.71, N.265, S.281, N.282, N.342, E.456
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.42: 8 residues within 4Å:- Chain C: A.69, K.70, Y.71, N.265, S.281, N.282, N.342, E.456
No protein-ligand interaction detected (PLIP)- 12 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.7: 6 residues within 4Å:- Chain A: Q.306, T.333, D.335, R.428, N.467
- Ligands: MAN.58
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.9: 3 residues within 4Å:- Chain A: W.530, N.532, K.591
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.12: 6 residues within 4Å:- Chain A: N.826, H.829
- Chain C: D.922, V.959, M.1020
- Ligands: MAN.77
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.13: 1 residues within 4Å:- Chain A: N.847
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.25: 6 residues within 4Å:- Chain B: Q.306, T.333, D.335, R.428, N.467
- Ligands: MAN.69
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.27: 3 residues within 4Å:- Chain B: W.530, N.532, K.591
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.30: 6 residues within 4Å:- Chain A: D.922, V.959, M.1020
- Chain B: N.826, H.829
- Ligands: MAN.65
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.31: 1 residues within 4Å:- Chain B: N.847
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.43: 6 residues within 4Å:- Chain C: Q.306, T.333, D.335, R.428, N.467
- Ligands: MAN.81
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.45: 3 residues within 4Å:- Chain C: W.530, N.532, K.591
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.48: 6 residues within 4Å:- Chain B: D.922, V.959, M.1020
- Chain C: N.826, H.829
- Ligands: MAN.76
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.49: 1 residues within 4Å:- Chain C: N.847
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUC.15: 1 residues within 4Å:- Chain A: N.934
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-FUC.33: 1 residues within 4Å:- Chain B: N.934
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-FUC.51: 1 residues within 4Å:- Chain C: N.934
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.16: 5 residues within 4Å:- Chain A: N.1073, G.1076, N.1077, A.1088, T.1091
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.34: 5 residues within 4Å:- Chain B: N.1073, G.1076, N.1077, A.1088, T.1091
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.52: 5 residues within 4Å:- Chain C: N.1073, G.1076, N.1077, A.1088, T.1091
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.17: 6 residues within 4Å:- Chain A: H.829, E.831, D.835, N.1203, L.1226
- Chain C: D.916
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:E.831
NAG-NAG-BMA-MAN-MAN-MAN-MAN.35: 6 residues within 4Å:- Chain A: D.916
- Chain B: H.829, E.831, D.835, N.1203, L.1226
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.831
NAG-NAG-BMA-MAN-MAN-MAN-MAN.53: 6 residues within 4Å:- Chain B: D.916
- Chain C: H.829, E.831, D.835, N.1203, L.1226
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:E.831
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.55: 2 residues within 4Å:- Chain A: G.242, N.245
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain A: D.364, N.365
Ligand excluded by PLIPNAG.57: 4 residues within 4Å:- Chain A: V.320, D.356, H.359, N.449
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain A: N.570, G.571, S.572
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain A: N.575, V.576, T.577
Ligand excluded by PLIPNAG.61: 1 residues within 4Å:- Chain A: N.804
Ligand excluded by PLIPNAG.62: 2 residues within 4Å:- Chain A: N.1242, T.1295
Ligand excluded by PLIPNAG.63: 1 residues within 4Å:- Chain A: N.1260
Ligand excluded by PLIPNAG.64: 2 residues within 4Å:- Chain A: D.1308, N.1310
Ligand excluded by PLIPNAG.66: 2 residues within 4Å:- Chain B: G.242, N.245
Ligand excluded by PLIPNAG.67: 2 residues within 4Å:- Chain B: D.364, N.365
Ligand excluded by PLIPNAG.68: 4 residues within 4Å:- Chain B: V.320, D.356, H.359, N.449
Ligand excluded by PLIPNAG.70: 3 residues within 4Å:- Chain B: N.570, G.571, S.572
Ligand excluded by PLIPNAG.71: 3 residues within 4Å:- Chain B: N.575, V.576, T.577
Ligand excluded by PLIPNAG.72: 1 residues within 4Å:- Chain B: N.804
Ligand excluded by PLIPNAG.73: 2 residues within 4Å:- Chain B: N.1242, T.1295
Ligand excluded by PLIPNAG.74: 1 residues within 4Å:- Chain B: N.1260
Ligand excluded by PLIPNAG.75: 2 residues within 4Å:- Chain B: D.1308, N.1310
Ligand excluded by PLIPNAG.78: 2 residues within 4Å:- Chain C: G.242, N.245
Ligand excluded by PLIPNAG.79: 2 residues within 4Å:- Chain C: D.364, N.365
Ligand excluded by PLIPNAG.80: 4 residues within 4Å:- Chain C: V.320, D.356, H.359, N.449
Ligand excluded by PLIPNAG.82: 3 residues within 4Å:- Chain C: N.570, G.571, S.572
Ligand excluded by PLIPNAG.83: 3 residues within 4Å:- Chain C: N.575, V.576, T.577
Ligand excluded by PLIPNAG.84: 1 residues within 4Å:- Chain C: N.804
Ligand excluded by PLIPNAG.85: 2 residues within 4Å:- Chain C: N.1242, T.1295
Ligand excluded by PLIPNAG.86: 1 residues within 4Å:- Chain C: N.1260
Ligand excluded by PLIPNAG.87: 2 residues within 4Å:- Chain C: D.1308, N.1310
Ligand excluded by PLIP- 6 x MAN: alpha-D-mannopyranose(Non-functional Binders)
MAN.58: 2 residues within 4Å:- Ligands: NAG-NAG-BMA-MAN.7, NAG-NAG-BMA-MAN.7
No protein-ligand interaction detected (PLIP)MAN.65: 2 residues within 4Å:- Ligands: NAG-NAG-BMA-MAN.30, NAG-NAG-BMA-MAN.30
No protein-ligand interaction detected (PLIP)MAN.69: 2 residues within 4Å:- Ligands: NAG-NAG-BMA-MAN.25, NAG-NAG-BMA-MAN.25
No protein-ligand interaction detected (PLIP)MAN.76: 2 residues within 4Å:- Ligands: NAG-NAG-BMA-MAN.48, NAG-NAG-BMA-MAN.48
No protein-ligand interaction detected (PLIP)MAN.77: 2 residues within 4Å:- Ligands: NAG-NAG-BMA-MAN.12, NAG-NAG-BMA-MAN.12
No protein-ligand interaction detected (PLIP)MAN.81: 2 residues within 4Å:- Ligands: NAG-NAG-BMA-MAN.43, NAG-NAG-BMA-MAN.43
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, T.J. et al., Cryo-EM analysis of a feline coronavirus spike protein reveals a unique structure and camouflaging glycans. Proc.Natl.Acad.Sci.USA (2020)
- Release Date
- 2020-01-15
- Peptides
- Feline Infectious Peritonitis Virus Spike Protein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x MAN: alpha-D-mannopyranose(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, T.J. et al., Cryo-EM analysis of a feline coronavirus spike protein reveals a unique structure and camouflaging glycans. Proc.Natl.Acad.Sci.USA (2020)
- Release Date
- 2020-01-15
- Peptides
- Feline Infectious Peritonitis Virus Spike Protein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C